MONMOUTH JUNCTION, NJ–(Marketwired – March 11, 2015) – DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company’s Chief Executive Officer, Dr. Kira Sheinerman, will present and discuss the company’s technology platform based on the analysis of organ-enriched microRNAs in plasma for early detection and monitoring of disease at the Extracellular Biomarkers Summit, taking place in Cambridge, MA, March 16-18.